Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare

>>

Canada Erectile Dysfunction Treatment Market


Canada Erectile Dysfunction Treatment Market - Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook 2016-2026

Report code: SDMRHE587759 | Industry: Healthcare | Published On: 7/26/2019


Erectile Dysfunction (ED), also known as impotence, is the inability to maintain erection of the penis necessary for sexual intercourse. Erectile dysfunction is mostly related to neurologic, vascular, hormonal, and psychological disorders. The excessive use of drugs may also lead to erectile dysfunction in many cases. Erectile dysfunction treatments are used to cure patients and can be done through drugs or devices.
The Canada erectile dysfunction treatment market was valued at US$ 292.3 Mn in 2018 and is expected to reach US$ 430.5 Mn by the year 2026, growing at a significant CAGR during the forecast period. The Canada erectile dysfunction treatment market is mainly driven by the increasing awareness about erectile dysfunction, as well as the rising incidence of erectile dysfunction. Approximately, 50% of men between the age group of 40-70 years gets affected by erectile dysfunction. Advancements in the currently available treatment options are also driving the growth of the market.
The erectile dysfunction treatment market is segmented on the basis of treatment type and end-user. Based on the treatment type, the market is categorized as drugs and devices. Among these, the drugs segment dominated the market in the year 2018, with a market share of 91.9%. The drugs segment is expected to grow with a CAGR of 5.1% during the forecast period. There are various developments in erectile dysfunction drugs to cure the disease. The major drugs used for erectile dysfunction treatment include Sildenafil, Tadalafil, and Vardenafil.

Chapter  1  Preface
1.1    Report  Description
1.1.1    Purpose  of  the  Report
1.1.2    Target  Audience
1.1.3    USP  and  Key  End-user
1.2    Research  Scope
1.3    Research  Methodology
1.3.1    Phase  I  –  Secondary  Research
1.3.2    Phase  II  –  Primary  Research
1.3.3    Phase  III  –  Expert  Panel  Review
1.3.4    Approach  Adopted
1.3.4.1    Top-Down  Approach
1.3.4.2    Bottom-Up  Approach
1.3.5    Assumptions
1.4    Market  Segmentation  Scope
Chapter  2  Executive  Summary
2.1    Market  Summary
2.1.1    Canada  Erectile  Dysfunction  Treatment  Market,  2016-2026,  (US$  Mn)
2.1    Market  Snapshot:  Canada  Erectile  Dysfunction  Treatment  Market
2.2    Market  Dynamics
2.3    Canada  Erectile  Dysfunction  Treatment  Market,  by  Segment,  2018
2.3.1    Canada  Erectile  Dysfunction  Treatment  Market,  by  Treatment  Type,  2018,  (US$  Mn)
2.3.2    Canada  Erectile  Dysfunction  Treatment  Market,  by  End-user,  2018  (US$  Mn)
Chapter  3  Market  Dynamics
3.1    Market  Overview
3.2    Market  Drivers
3.2.1    Increasing  awareness  about  erectile  dysfunction
3.2.1    Rising  incidence  of  erectile  dysfunction
3.3    Market  Restraints
3.3.1    Social  stigma  associated  with  erectile  dysfunction
3.4    Market  Opportunities
3.4.1    Advancement  in  the  treatment  options  for  erectile  dysfunction
3.5    Industry  SWOT  Analysis
Chapter  4  Canada  Erectile  Dysfunction  Treatment  Market,  by  Treatment  Type
4.1    Market  Overview,  by  Treatment  Type
4.1.1  Canada  Erectile  Dysfunction  Treatment  Market,  by  Treatment  Type,  2016-2026  (US$  Mn)
4.1.2    Incremental  Opportunity,  by  Treatment  Type,  From  2018-2026
4.2    Drugs
4.2.1    Canada  Erectile  Dysfunction  Treatment  Market,  by  Drugs,  2016-2026,  (US$  Mn)
4.3    Devices
4.3.1    Canada  Erectile  Dysfunction  Treatment  Market,  by  Devices,  2016-2026,  (US$  Mn)
Chapter  5  Canada  Erectile  Dysfunction  Treatment  Market,  by  End-user
5.1    Market  Overview,  by  End-user
5.1.1    Canada  Erectile  Dysfunction  Treatment  Market,  by  End-user,  2016-2026  (US$  Mn)
5.1.2    Incremental  Opportunity,  by  End-user,  From  2018-2026
5.2    Hospitals
5.2.1    Canada  Erectile  Dysfunction  Treatment  Market,  by  Hospitals,  2016-2026,  (US$  Mn)
5.3    Speciality  Clinics  (ED  Clinics)
5.3.1  Canada  Erectile  Dysfunction  Treatment  Market,  by  Speciality  Clinics  (ED  Clinics),  2016-2026,  (US$  Mn)
5.4    Others
5.4.1    Canada  Erectile  Dysfunction  Treatment  Market,  by  Others,  2016-2026,  (US$  Mn)

Chapter  6  Competitive  Intelligence
6.1    Market  Players  Present  in  Market  Life  Cycle
6.2    Top  5  Players  Comparison
6.3    Market  Positioning  of  Key  Players,  2018
6.4    Market  Players  Mapping
6.4.1    By  Treatment  Type
6.4.2    By  End-user
6.5    Strategies  Adopted  by  Key  Market  Players
6.6    Recent  Developments  in  the  Market
6.6.1    Mergers  &  Acquisitions,  Partnership,  New  Product  Developments
6.7    Operational  Efficiency  Comparison  by  Key  Players
Chapter  7  Company  Profiles
7.1    Coloplast  Group
7.1.1    Coloplast  Group  Overview
7.1.2    Key  Stakeholders/Person  in  Coloplast  Group
7.1.3    Coloplast  Group  Products  Portfolio
7.1.4    Coloplast  Group  Financial  Overview
7.1.5    Coloplast  Group  News/Recent  Developments
7.2    Boston  Scientific  Corporation
7.2.1    Boston  Scientific  Corporation  Overview
7.2.2    Key  Stakeholders/Person  in  Boston  Scientific  Corporation
7.2.3    Boston  Scientific  Corporation  Products  Portfolio
7.2.4    Boston  Scientific  Corporation  Financial  Overview
7.2.5    Boston  Scientific  Corporation  News/Recent  Developments
7.3    Zephyr  Surgical  Implants  SARL
7.3.1    Zephyr  Surgical  Implants  SARL  Overview
7.3.2    Key  Stakeholders/Person  in  Zephyr  Surgical  Implants  SARL
7.3.3    Zephyr  Surgical  Implants  SARL  Products  Portfolio
7.3.4    Zephyr  Surgical  Implants  SARL  Financial  Overview
7.3.5    Zephyr  Surgical  Implants  SARL  News/Recent  Developments
7.4    Medispec
7.4.1    Medispec  Overview
7.4.2    Key  Stakeholders/Person  in  Medispec
7.4.3    Medispec  Products  Portfolio
7.4.4    Medispec  Financial  Overview
7.4.5    Medispec  News/Recent  Developments
7.5    KARL  STORZ  SE  &  Co.  KG
7.5.1    KARL  STORZ  SE  &  Co.  KG  Overview
7.5.2    Key  Stakeholders/Person  in  KARL  STORZ  SE  &  Co.  KG
7.5.3    KARL  STORZ  SE  &  Co.  KG  Products  Portfolio
7.5.4    KARL  STORZ  SE  &  Co.  KG  Financial  Overview
7.5.5    KARL  STORZ  SE  &  Co.  KG  News/Recent  Developments
7.6    Augusta  Medical  Systems  LLC
7.6.1    Augusta  Medical  Systems  LLC  Overview
7.6.2    Key  Stakeholders/Person  in  Augusta  Medical  Systems  LLC
7.6.3    Augusta  Medical  Systems  LLC  Products  Portfolio
7.6.4    Augusta  Medical  Systems  LLC  Financial  Overview
7.6.5    Augusta  Medical  Systems  LLC  News/Recent  Developments
TABLE 1 Market Snapshot: Canada Erectile Dysfunction Treatment Market Value
TABLE 2 Canada Erectile Dysfunction Treatment Market, by Treatment Type, 2016-2026
TABLE 3 Canada Erectile Dysfunction Treatment Market, by End-user, 2016-2026 (US$ Mn)
TABLE 4 Top 5 Players Comparison
TABLE 5 Top Players Market Mapping – By Treatment Type
TABLE 6 Top Players Market Mapping – By End-user
TABLE 7 Strategies Adopted by Key Market Players
TABLE 8 Mergers & Acquisitions, Partnership, New Product Developments
TABLE 9 Coloplast Group Overview
TABLE 10 Key Stakeholders/Person in Coloplast Group
TABLE 11 Coloplast Group Product Portfolio
TABLE 12 Coloplast Group News/Recent Developments
TABLE 13 Boston Scientific Corporation Overview
TABLE 14 Key Stakeholders/Person in Boston Scientific Corporation
TABLE 15 Boston Scientific Corporation Product Portfolio
TABLE 16 Boston Scientific Corporation News/Recent Developments
TABLE 17 Zephyr Surgical Implants SARL Overview
TABLE 18 Key Stakeholders/Person in Zephyr Surgical Implants SARL
TABLE 19 Zephyr Surgical Implants SARL Product Portfolio
TABLE 20 Zephyr Surgical Implants SARL News/Recent Developments
TABLE 21 Medispec Overview
TABLE 22 Key Stakeholders/Person in Medispec
TABLE 23 Medispec Product Portfolio
TABLE 24 Medispec News/Recent Developments
TABLE 25 KARL STORZ SE & Co. KG Overview
TABLE 26 Key Stakeholders/Person in KARL STORZ SE & Co. KG
TABLE 27 KARL STORZ SE & Co. KG Product Portfolio
TABLE 28 KARL STORZ SE & Co. KG News/Recent Developments
TABLE 29 Augusta Medical Systems LLC Overview
TABLE 30 Key Stakeholders/Person in Augusta Medical Systems LLC
TABLE 31 Augusta Medical Systems LLC Product Portfolio
TABLE 32 Augusta Medical Systems LLC News/Recent Developments
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT